AdjuTec Pharma
Oslo, Norway· Est. 2015
Develops antibody-based therapies and vaccines targeting antibiotic-resistant bacterial infections.
Private Company
Total funding raised: $12M
About
Develops antibody-based therapies and vaccines targeting antibiotic-resistant bacterial infections.
Infectious DiseaseAntibodies
Funding History
2Total raised:$12M
Series A$10MDec 15, 2021
Seed$2MOct 15, 2019